Duchenne Muscular Dystrophy Treatment Market
According to Intent Market Research, the Duchenne Muscular Dystrophy Treatment Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 15.4% to touch USD 7.6 billion by 2030. The Duchenne Muscular Dystrophy Treatment Market is dominated by key players such as Sarepta Therapeutics, Inc., Pfizer Inc., Roche Holding AG, Solid Biosciences, Santhera Pharmaceuticals, GlaxoSmithKline, BioMarin Pharmaceutical, Bristol-Myers Squibb, Eli Lilly and Company, Vertex Pharmaceuticals, Audentes Therapeutics, PTC Therapeutics, Astellas Pharma Inc., Novartis AG, Wave Life Sciences